Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
52
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer

E DuTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Lin WangTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Chang-ying LiTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Chang-wen ZhangTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Yan-chun QuTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Ran-lu LiuTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Yong XuTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
,
Kuo YangTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Zhi-hong ZhangTianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 2561-2567 | Published online: 15 May 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tian-Hua Yue & Wei Xing. (2020) 125I Seed Brachytherapy Combined with Single-Agent Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer in the Elderly: A Valuable Solution. OncoTargets and Therapy 13, pages 10581-10591.
Read now

Articles from other publishers (7)

Anthony T. Nguyen, Chung-Tang Spencer Liu & Mitchell Kamrava. (2023) A “scoping” review of prostate brachytherapy and immune responses. Brachytherapy 22:1, pages 21-29.
Crossref
Yu Zhang, Yong Wei, Shun Jiang, Yanmei Dang, Yu Yang, Wenren Zuo, Qingyi Zhu, Ping Liu, Yanhong Gao & Shan Lu. (2022) Traditional Chinese medicine CFF-1 exerts a potent anti-tumor immunity to hinder tumor growth and metastasis in prostate cancer through EGFR/JAK1/STAT3 pathway to inhibit PD-1/PD-L1 checkpoint signaling. Phytomedicine 99, pages 153939.
Crossref
Shuhua Wei, Chunxiao Li, Mengyuan Li, Yan Xiong, Yuliang Jiang, Haitao Sun, Bin Qiu, Christopher J. Lin & Junjie Wang. (2021) Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions. Frontiers in Oncology 11.
Crossref
Hang Li, Li Chen, Guang-Yu Zhu, Xijuan Yao, Rui Dong & Jin-He Guo. (2021) Interventional Treatment for Cholangiocarcinoma. Frontiers in Oncology 11.
Crossref
Matthew C. Knox, Jie Ni, Andrej Bece, Joseph Bucci, Yaw Chin, Peter H. Graham & Yong Li. (2020) A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications. Frontiers in Immunology 11.
Crossref
Qing Pang, Lei Zhou, Xiao-Si Hu, Yong Wang, Zhong-Ran Man, Song Yang, Wei Wang, Zhen Qian, Hao Jin & Hui-Chun Liu. (2019) Biliary stenting alone versus biliary stenting combined with 125I particles intracavitary irradiation for the treatment of advanced cholangiocarcinoma. Scientific Reports 9:1.
Crossref
X. Hu, Q. Pang, H. Liu, Z. Qian, H. Jin, L. Zhou, Y. Wang, Z. Man, Z. Li & S. Yang. (2018) Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation. Clinical and Translational Oncology 21:5, pages 665-673.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.